
University of Iowa makes professional-grade face masks to protect workers from COVID-19

IDT joins effort to produce virus test materials
Viewpoint Awarded $2M NCI Phase II SBIR to conduct Phase 1 clinical trial at Mayo Clinic
Viewpoint Molecular Targeting, Inc., a University of Iowa start-up pharmaceutical company that has developed novel therapy and companion diagnostics for cancer, announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant valued at $2 million from the National Cancer Institute (NCI) The award will support preclinical development and a Phase 1 clinical imaging trial of it’s VMT01 companion diagnostic in advance of therapeutic trials.
Viewpoint Awarded $300K NIH Phase I SBIR
10,000 Small Businesses

University of Iowa prototyping hub aims to win hearts and minds - by 3D printing them

Oregon State University Includes Santos in Graduate Digital Human Modeling Course

IOWA CITY, Iowa - Following the successful introduction of its first digital human modeling (DHM) course in 2018, Oregon State University (OSU) conducted a successful pilot of a computational ergonomics design course for advanced degrees last year. Now, the School of Mechanical, Industrial and Manufacturing Engineering plans to introduce Santos technologies into Digital Human Modeling for Design.
SantosHuman Inc., U Ottawa, and U Waterloo Partner to Research Canadian Soldier Performance Tool

Pages
